Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3839-3844

  Xi, Long Fu ^a,b   Critchlow, Cathy W ^a,c   Wheeler, Cosette M ^d   Koutsky, Laura A ^a   Galloway, Denise A ^b,c   Kuypers, Jane ^b   Hughes, James P ^a   Hawes, Stephen E ^a   Surawicz, Christina ^b   Goldbaum, Gary ^a   Holmes, King K ^b   Kiviat, Nancy B ^b,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANUS CARCINOMA; ARTICLE; CANCER RISK; CARCINOMA IN SITU; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

ANUS NEOPLASMS; CARCINOMA IN SITU; DNA, VIRAL; HUMANS; MALE; PAPILLOMAVIRIDAE; RISK;

EID: 17144460506     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Melbye, M., Rabkin, C., Frisch, M., and Biggar, R. J. Changing patterns of anal cancer incidence in the United States, 1940-1989, Am. J. Epidemiol., 139: 772-780, 1994.
2. Koblin, B. A., Hessol, N. A., Zauber, A. G., Taylor, P. E., Buchbinder, S. P., Katz, M. H., and Stevens, C. E. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am. J. Epidemiol., 144: 916-923, 1996.
3. Frisch, M., Glimelius, B., van-den-Brule, A. J., Wohlfahrt, J., Meijer, C. J., Walboomers, J. M., Goldman, S., Svensson, C., Adami, H. O., and Melbye, M. Sexually transmitted infection as a cause of anal cancer. N. Engl. J. Med., 337: 1350-1358, 1997.
4. de-Ruiter, A., and Mindel, A. Anal intraepithelial neoplasia. Eur. J. Cancer, 27: 1343-1345, 1991.
5. Kiviat, N. B., Critchlow, C. W., Holmes, K. K., Kuypers, J., Sayer, J., Dunphy, C., Surawicz, C., Kirby, P., Wood, R., and Daling, J. R. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS, 7: 43-49, 1993.
6. Critchlow, C. W., Surawicz, C. M., Holmes, K. K., Kuypers, J., Daling, J. R., Hawes, S. E., Goldbaum, G. M., Sayer, J., Hurt, C., Dunphy, C., and Kiviat, N. B. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS, 9: 1255-1262, 1995.
7. Melbye, M., Cote, T. R., Kessler, L., Gail, M., and Biggar, R. J. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet, 343: 636-639, 1994.
8. Palefsky, J. M., Shiboski, S., and Moss, A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J. Acquired Immune Defic. Syndr., 7: 599-606, 1994.
9. May, M., Dong, X. P., Stubenrauch, F., Fuchs, P. G., and Pfister, H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J., 13: 1460-1466, 1994.
10. Mittal, R., Pater, A., and Pater, M. M. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA protein interactions. J. Virol., 67: 5656-5659, 1993.
11. Conrad-Stoppler, M., Ching, K., Stoppler, H., Clancy, K., Schlegel, R., and Icenogle, J. P. Natural variants of human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol., 70: 6987-6993, 1996.
12. Hecht, J. L., Kadish, A. S., Jiang, G., and Burk, R. D. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer, 60: 369-376, 1995.
13. Xi, L. F., Koutsky, L. A., Galloway, D. A., Kuypers, J., Hughes, J. P., Wheeler, C. M., Holmes, K. K., and Kiviat, N. B. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. (Bethesda), 89: 796-802, 1997.
14. Kuypers, J. M., Critchlow, C. W., Gravitt, P. E., Vernon, D. A., Sayer, J. B., Manos, M. M., and Kiviat, N. B. Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J. Clin. Microbiol., 31: 1003-1006, 1993.
15. Xi, L. F., Demers, G. W., Kiviat, N. B., Kuypers, J., Beckmann, A. M., and Galloway, D. A. Sequence variation in the noncoding region of human papillomavirus type 16 detected by single strand conformation polymorphism analysis. J. Infect. Dis., 168: 610-617, 1993.
16. Seedorf, K., Krämmer, G., Dürst, M., Suhai, S., and Röwekamp, W. G. Human papillomavirus type 16 DNA sequence. Virology, 145: 181-185, 1985.
17. Baker, C. C., Phelps, W. C., Lindgren, V., Braun, M. J., Gonda, M. A., and Howley, P. M. Structural and transcriptional analysis of human papillomavirus type 16 sequence in cervical carcinoma cell lines. J. Virol., 61: 962-971, 1987.
18. Wheeler, C. M., Yamada, T., Hildesheim, A., and Jenison, S. A. HPV16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol., 35: 11-19, 1997.
19. Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A. C. M., Hildesheim, A., and Jenison, S. A. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol., 69: 7743-7753, 1995.
20. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. J. Am. Med. Assoc., 262: 931-934, 1989.
21. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B, 34: 187-220, 1972.
22. Andersen, P. K., and Gill, R. D. Cox's regression model for counting process: a large sample study. Ann. Stat., 10: 1100-1120, 1982.
23. Self, S. G. An adaptive weighted log-rank test with application to cancer prevention and screening trials. Biometrics, 47: 975-986, 1991.
24. Lipsitz, S. R., Laird, N. M., and Harrington, D. P. Generalized estimating equations for correlated binary data: using the odds ratio as a measure of association. Biometrika, 78: 153-160, 1991.
25. Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C., Paavonen, J., Beckmann, A. M. DeRouen, T. A., Galloway, D. A., Vernon, D., and Kiviat, N. B. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med., 327: 1272-1278, 1992.
26. Muñoz, N., and Bosch, F. X. HPV and cervical neoplasia: review of case-control and cohort studies. In: N. Muñoz, F. X. Bosch, and K. V. Shah (eds.), Epidemiology of Cervical Cancer and Human Papillomavirus, pp. 251-261. IARC Scientific Publ. No. 119. Lyon, France: IARC, 1992.
27. Stewart, A. C., Eriksson, A. M., Manos, M. M., Munoz, N., Bosch, F. X., Peto, J., and Wheeler, M. C. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol., 70: 3127-3136, 1996.
28. Chan, S. Y., Ho, L., Ong, C. K., Chow, V., Drescher, B., Dürst, M., ter-Meulen, J., Villa, L., Luande, J., Mgaya, H. N., and Bernard, H. U. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol., 66: 2057-2066, 1992.
29. Ho, L., Shan, S. Y., Chow, V., Burk, R. D., Das, B. C., Fujinaga, K., Icenogle, J. P., Kahn, T., Kiviat, N. B., Lancaster, W., Mavromara-Nazos, P., Labropoulou, V., Mitrani-Rosenbaum, S., Norrild, B., Pillai, M. R., Stoerker, J., Syrjaenen, K., Syrjaenen, S., Tay, S. K., Villa, L. L., Wheeler, C. M., Williamson, A. L., and Bernard, H. U. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol., 67: 6413-6423, 1993.
30. Apple, R. J., Becker, T. M., Wheeler, C. M., and Erlich, H. A. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J. Natl. Cancer Inst. (Bethesda), 87: 427-436, 1995.
31. Ellis, J. R. M., Keating, P. J., Baird, J., Hounsell, E. F., Renouf, D. V., Rowe, M., Hopkins, D., Duggan-Keen, M. F., Bartholomew, J. S., Young, L. S., and Stern P. L. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med., 1: 464-470, 1995.
32. Ellis, J. R. M., Etherington, I., Galloway, D. A., and Young, L. S. Antibody response to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infection with a variant HPV16. Lancet, 349: 1069-1070, 1997.